High Free Cash Flow Stocks
LH is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
LABCORP HOLDINGS INC (LH) Stock Price & Overview
NYSE:LH • US5049221055
Current stock price
273.72 USD
+0.98 (+0.36%)
At close:
274.21 USD
+0.49 (+0.18%)
After Hours:
The current stock price of LH is 273.72 USD. Today LH is up by 0.36%. In the past month the price decreased by -0.8%. In the past year, price increased by 21.65%.
LH Key Statistics
52-Week Range209.375 - 293.72
Current LH stock price positioned within its 52-week range.
1-Month Range260.866 - 276.58
Current LH stock price positioned within its 1-month range.
- Market Cap
- 22.555B
- P/E
- 16.65
- Fwd P/E
- 14.98
- EPS (TTM)
- 16.44
- Dividend Yield
- 1.07%
LH Stock Performance
Today
+0.36%
1 Week
+1.99%
1 Month
-0.80%
3 Months
+8.77%
Longer-term
6 Months -1.16%
1 Year +21.65%
2 Years +35.93%
3 Years +20.74%
5 Years +2.95%
10 Years +118.42%
LH Stock Chart
LH Stock Screens
LH currently appears in the following ChartMill screener lists.
Value Stocks with Strong Balance Sheets
LH is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
LH Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to LH. When comparing the yearly performance of all stocks, LH turns out to be only a medium performer in the overall market: it outperformed 67.97% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
LH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LH. Both the profitability and the financial health of LH get a neutral evaluation. Nothing too spectacular is happening here.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LH Earnings
On February 17, 2026 LH reported an EPS of 4.07 and a revenue of 3.52B. The company beat EPS expectations (0.26% surprise) and missed revenue expectations (-4.07% surprise).
Next Earnings DateApr 27, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported$4.07
Revenue Reported3.516B
EPS Surprise 0.26%
Revenue Surprise -4.07%
LH Forecast & Estimates
29 analysts have analysed LH and the average price target is 311.79 USD. This implies a price increase of 13.91% is expected in the next year compared to the current price of 273.72.
For the next year, analysts expect an EPS growth of 11.11% and a revenue growth 4.86% for LH
Analysts
Analysts82.76
Price Target311.79 (13.91%)
EPS Next Y11.11%
Revenue Next Year4.86%
LH Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Services LH Financial Highlights
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 16.44. The EPS increased by 12.83% compared to the year before.
Income Statements
Revenue(TTM)13.95B
Net Income(TTM)876.50M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.28% | ||
| ROA | 4.77% | ||
| ROE | 10.17% | ||
| Debt/Equity | 0.6 |
Chartmill High Growth Momentum
EPS Q2Q%17.97%
Sales Q2Q%5.6%
EPS 1Y (TTM)12.83%
Revenue 1Y (TTM)7.25%
LH Ownership
Ownership
Inst Owners99.89%
Shares82.40M
Float82.07M
Ins Owners0.34%
Short Float %3.65%
Short Ratio4.42
LH Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.13 | 93.495B | ||
| CI | THE CIGNA GROUP | 8.64 | 71.194B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 103.73 | 27.674B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.44 | 21.757B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.308B | ||
| DVA | DAVITA INC | 10.29 | 9.725B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.08 | 8.291B | ||
| CHE | CHEMED CORP | 15.69 | 5.241B | ||
| AGL | AGILON HEALTH INC | N/A | 4.456B | ||
| HIMS | HIMS & HERS HEALTH INC | 35.05 | 4.363B | ||
| OPCH | OPTION CARE HEALTH INC | 14.4 | 4.298B | ||
| RDNT | RADNET INC | 68.87 | 4.252B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LH
Company Profile
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Company Info
IPO: 1991-04-24
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 71000
Phone: 18009279800
LABCORP HOLDINGS INC / LH FAQ
What does LABCORP HOLDINGS INC do?
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Can you provide the latest stock price for LABCORP HOLDINGS INC?
The current stock price of LH is 273.72 USD. The price increased by 0.36% in the last trading session.
Does LABCORP HOLDINGS INC pay dividends?
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.07%. The yearly dividend amount is currently 2.91.
How is the ChartMill rating for LABCORP HOLDINGS INC?
LH has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Should I buy LH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.
What is LABCORP HOLDINGS INC worth?
LABCORP HOLDINGS INC (LH) has a market capitalization of 22.55B USD. This makes LH a Large Cap stock.
What is the Short Interest ratio of LABCORP HOLDINGS INC (LH) stock?
The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.65% of its float.